FrancophonIA/ELRC3.0 huggingface dataset:
English: The addition of ribavirin to Epclusa may also be considered for patients who have compensated liver cirrhosis (scarring of the liver but the liver is still able to work adequately) and are infected with genotype 3 hepatitis C virus, a variety which is more difficult to treat.
Croatian: Mogućnost dodavanja ribavirina lijeku Epclusa može se razmotriti i u bolesnika s kompenziranom cirozom jetre (čija jetra ima ožiljke, ali još uvijek normalno radi) i u bolesnika koji su zaraženi virusom hepatitisa C genotipa 3, varijante koja se teže liječi.
English: Epclusa contains the active substances sofosbuvir and velpatasvir.
Croatian: Lijek Epclusa sadrži djelatne tvari sofosbuvir i velpatasvir.
English: What benefits of Epclusa have been shown in studies?
Croatian: Koje su koristi lijeka Epclusa utvrđene u ispitivanjima?
English: How is Epclusa used?
Croatian: Kako se Epclusa koristi?
English: Epclusa on its own has been shown to be highly effective in clearing the hepatitis C virus from the blood of patients whose liver is able to work adequately.
Croatian: Pokazalo se da je lijek Epclusa kada se primjenjuje kao monoterapija izrazito učinkovit u uklanjanju virusa hepatitisa C iz krvi bolesnika čija jetra još uvijek normalno radi.
English: For the full list of side effects or restrictions with Epclusa, see the package leaflet.
Croatian: Potpuni popis nuspojava ili ograničenja zabilježenih pri primjeni lijeka Epclusa potražite u uputi o lijeku.
English: How does Epclusa work?
Croatian: Kako djeluje Epclusa?
English: Results showed that patients treated for 12 weeks with Epclusa in combination with ribavirin obtained the best results, with around 94% of patients (82 out of 87) testing negative for the virus 12 weeks after the end of treatment.
Croatian: Otprilike 94 % bolesnika (82 od 87) imalo je negativne rezultate testiranja na prisutnost virusa 12 tjedana nakon završetka liječenja.
English: Clearance was also very high in patients whose liver is not working properly (Child-Pugh class B cirrhosis), when treated with Epclusa in combination with ribavirin.
Croatian: Uklanjanje virusa zabilježeno je kod svih genotipova, uključujući genotip 3. Uklanjanje je također bilo vrlo uspješno u bolesnika čija jetra ne funkcionira normalno (ciroza Child-Pugh stadija B) nakon liječenja kombinacijom lijeka Epclusa i ribavirina.
English: Epclusa is taken with another medicine called ribavirin in patients with decompensated liver disease (when the liver is not working properly).
Croatian: U bolesnika s dekompenziranom bolešću jetre (čija jetra ne funkcionira normalno) lijek Epclusa uzima se s drugim lijekom koji se naziva ribavirin.
English: 112 capsules
Croatian: 112 kapsula
English: UNIQUE IDENTIFIER - 2D BARCODE 2D barcode carrying the unique identifier included.
Croatian: 17. JEDINSTVENA IDENTIFIKACIJSKA OZNAKA - 2D BARKOD 2D barkod koji nosi jedinstvenu identifikacijsku oznaku je uključen.
English: • if you are taking riociguat.
Croatian: - ako uzimate riociguat.
English: UNIQUE IDENTIFIER - HUMAN READABLE DATA PC:
Croatian: JEDINSTVENA IDENTIFIKACIJSKA OZNAKA - PODACI RAZUMLJIVI ČOVJEKU PC:
English: MedDRA system organ class (V.14.0)
Croatian: MedDRA organski sustav (V.14.0)
English: • lose a large amount of body fluids (dehydration) which can occur when you sweat a lot or do not drink enough liquids.
Croatian: - izgubite veliku količinu tjelesne tekućine (dehidracija), što se može dogoditi kad se jako znojite ili ne pijete dovoljno tekućine.
English: Like all medicines, this medicine can cause side effects, although not everybody gets them.
Croatian: Kao i svi lijekovi, ovaj lijek može uzrokovati nuspojave, iako se neće javiti kod svakoga
English: • take medicines for erectile dysfunction.
Croatian: - uzimate lijekove za erektilnu disfunkciju.
English: • Tell your doctor or pharmacist if you are already taking riociguat (see section 2).
Croatian: obavijestite svog liječnika ili ljekarnika ako već uzimate riociguat (vidjeti dio 2).
English: Children Mysildecard should not be given to children below 1 year of age.
Croatian: Djeca Mysildecard se ne smije davati djeci mlađoj od 1 godine.
English: Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy and embryonal/foetal development.
Croatian: Istraživanja na životinjama ne ukazuju na izravne niti neizravne štetne učinke na trudnoću i razvoj embrija i fetusa.
English: Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Croatian: Obavijestite svog liječnika ili ljekarnika ako uzimate, nedavno ste uezli ili biste mogli uzeti bilo koje druge lijekove:
English: The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal.
Croatian: Zahtjevi za podnošenje periodičkih izvješća o neškodiljvosti za ovaj lijek definirani su u referentnom popisu datuma EU (EURD popis) predviđenom člankom 107(c) stavkom 7 Direktive 2001/83/EZ i svim slijedećim ažuriranim verzijama objavljenima na europskom internetskom portalu za lijekove.
English: • if you have recently had a stroke, a heart attack or if you have severe liver disease or very low blood pressure (<90/50 mmHg).
Croatian: - ako ste nedavno imali moždani udar ili srčani udar, ili ako imate tešku bolest jetre ili vrlo nizak krvni tlak (< 90/50 mmHg).
English: If you forget to take Mysildecard, take a dose as soon as you remember, then continue to take your medicine at the usual times.
Croatian: Ako ste zaboravili uzeti Mysildecard, uzmite dozu čim se sjetite, a zatim nastavite uzimati lijek u uobičajeno vrijeme.
English: Physicians should advise patients who forget to take Mysildecard to take a dose as soon as possible and then continue with the normal dose.
Croatian: Liječnici trebaju savjetovati bolesnicima koji zaborave uzeti Mysildecard da uzmu dozu što prije, a zatim nastave s uobičajenom dozom.
English: There are no adequate and well controlled studies in lactating women.
Croatian: Nema adekvatnih i dobro kontroliranih studija kod dojilja.
English: Warnings and precautions Talk to your doctor before taking Mysildecard if you:
Croatian: Upozorenja i mjere opreza Obratite se svom liječniku prije nego uzmete Mysildecard ako:
English: Do not stop taking Mysildecard unless your doctor tells you to.
Croatian: Nemojte prestati uzimati Mysildecard ako Vam tako ne kaže liječnik.
English: Non-clinical data revealed no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity and carcinogenic potential, toxicity to reproduction and development.
Croatian: Neklinički podaci ne ukazuju na poseban rizik za ljude na temelju konvencionalnih ispitivanja sigurnosne farmakologije, toksičnosti ponovljenih doza, genotoksičnosti, kancerogenostikancerogenog potencijala, reproduktivne i razvojne toksičnosti.
English: What Mysildecard is and what it is used for
Croatian: Što je Mysildecard i za što se koristi
English: Prescribers should carefully assess the mother's clinical need for sildenafil and any potential adverse effects on the breast-fed child.
Croatian: Liječnici koji propisuju lijek trebaju pažljivo procijeniti majčinu kliničku potrebu za sildenafilom i sve potencijalne štetne učinke na dojeno dijete.
English: Mysildecard passes into your breast milk at very low levels and would not be expected to harm your baby.
Croatian: Mysildecard se izlučuje u majčino mlijeko u niskim razinama te se ne očekuje da će naštetiti vašem djetetu.
English: Mysildecard can cause a serious increase in the effects of these medicines.
Croatian: Mysildecard može uzrokovati ozbiljno pojačanje učinaka tih lijekova.
English: • Blood thinning medicines (for example warfarin) although these did not result in any side effect.
Croatian: lijekove za razrjeđivanje krvi (primjerice varfarin), iako oni nisu izazivali nuspojave.
English: In-vitro studies
Croatian: Ispitivanja in vitro
English: No clinical data are available regarding adverse events in breast-fed infants, but amounts ingested would not be expected to cause any adverse effects.
Croatian: Nisu dostupni podaci o štetnim događajima kod dojene dojenčadi, ali se ne očekuje da će unesene količine uzrokovati štetne događaje.
English: The causes of deaths were related to
Croatian: Uzroci smrti bili su povezani s PAH-om.
English: Mysildecard brings down blood pressure in the lungs by widening the blood vessels in the lungs.
Croatian: Mysildecard snižava krvni tlak u plućima tako što proširuje krvne žile u plućima.
English: Other medicines and Mysildecard
Croatian: Drugi lijekovi i Mysildecard
English: What Mysildecard contains - The active substance is sildenafil.
Croatian: Što Mysildecard sadrži - Djelatna tvar je sildenafil.
English: In case of clinical deterioration in spite of Mysildecard treatment, alternative therapies should be considered.
Croatian: U slučaju kliničkog pogoršanja unatoč liječenju lijekom Mysildecard, treba razmotriti druge mogućnosti liječenja.
English: Mysildecard film-coated tablets are white and round in shape.
Croatian: Mysildecard filmom obložene tablete su bijele i okrugle.
English: Limited data suggests that the abrupt discontinuation of sildenafil is not associated with rebound worsening of pulmonary arterial hypertension.
Croatian: Ograničeni podaci upućuju na to da nagli prekid primjene sildenafila nije povezan s povratnim pogoršanjem plućne arterijske hipertenzije.
English: Mysildecard has moderate influence on the ability to drive and use machines.
Croatian: Mysildecard umjereno utječe na sposobnost upravljanja vozilima i rada sa strojevima.
English: As dizziness and altered vision were reported in clinical trials with sildenafil, patients should be aware of how they might be affected by Mysildecard, before driving or using machines.
Croatian: S obzirom na to da su u kliničkim ispitivanjima sildenafila prijavljene omaglica i promjene vida, bolesnici moraju biti svjesni kako bi Mysildecard na njih mogao djelovati prije nego upravljaju vozilom ili rukuju strojevima.
English: If the clinical situation deteriorates, therapies that are recommended at the severe stage of the disease (e.g. epoprostenol) should be considered (see section 4.2).
Croatian: Ako se klinička situacija pogoršava, mora se razmotriti primjena lijekova koji se preporučuju u teškoj fazi bolesti (npr. epoprostenol) (vidjeti dio 4.2).
English: Taking more Mysildecard than you should may increase the risk of known side effects.
Croatian: Uzimanje više lijeka Mysildecard nego što je potrebno može povećati rizik od poznatih nuspojava.
English: The MAH shall perform the required pharmacovigilance activities and interventions detailed in the agreed RMP presented in Module 1.8.2. of the Marketing Authorisation and any agreed subsequent updates of the RMP.
Croatian: Nositelj odobrenja obavljat će zadatne farmakovigilancijske aktivnosti i intervencije, detaljno objašnjene u dogovorenom Planu upravljanja rizikom (RPM), koji se nalazi u Modulu 1.8.2 Odobrenja za stavljanje lijeka u promet, te svim sljedećim dogovorenim ažuriranim verzijama RMP-a.
English: • if you are taking a medicine to treat fungal infections such as ketoconazole or itraconazole or medicines containing ritonavir (for HIV).
Croatian: - ako uzimate lijekove za liječenje gljivičnih infekcija, kao što su ketokonazol ili itrakonazol, ili lijekove koji sadrže ritonavir (za liječenje HIV infekcije).
English: Mylan S.A.S 117 Allee des parcs 69800 Saint Priest France
Croatian: Mylan S.A.S 117 Allee des parcs 69800 Saint Priest Francuska
English: Mysildecard is used to treat adults and children and adolescents from 1 to 17 years old with high blood pressure in the blood vessels in the lungs (pulmonary arterial hypertension).
Croatian: Mysildecard se koristi za liječenje odraslih bolesnika te djece i adolescenata u dobi od 1 do 17 godina koji imaju visok krvni tlak u krvnim žilama u plućima (plućnu arterijsku hipertenziju).
English: When sildenafil and doxazosin were administered simultaneously to patients stabilised on doxazosin therapy, there were infrequent reports of patients who experienced symptomatic postural hypotension.
Croatian: Kada su se sildenafil i doksazosin istodobno primjenjivali u bolesnika stabiliziranih na terapiji doksazosinom, bilo je rijetkih prijava o bolesnicima u kojih se pojavila simptomatska posturalna hipotenzija.
English: What Mysildecard looks like and contents of the pack
Croatian: Kako Mysildecard izgleda i sadržaj pakiranja
English: If you take more Mysildecard than you should
Croatian: Ako uzmete više lijeka Mysildecard nego što ste trebali
English: What Mysildecard is and what it is used for What you need to know before you take Mysildecard How to take Mysildecard
Croatian: Što je Mysildecard i za što se koristi Što morate znati prije nego počnete uzimati Mysildecard Kako uzimati Mysildecard
English: Infections and infestations Common cellulitis, influenza, bronchitis, sinusitis, rhinitis, gastroenteritis
Croatian: Infekcije i infestacije često celulitis, gripa, bronhitis, sinusitis, rinitis, gastroenteritis
English: In general, any dose adjustment should be administered only after a careful benefit-risk assessment.
Croatian: Općenito, bilo kakva prilagodba doze smije se primjeniti samo nakon pažljive procjene koristi i rizika.
English: Mysildecard can cause dizziness and can affect vision.
Croatian: Mysildecard može izazvati omaglicu i može utjecati na vid.
English: 90 film-coated tablets 300 film-coated tablets 90 x 1 film-coated tablets
Croatian: 90 filmom obloženih tableta 300 filmom obloženih tableta 90 × 1 filmom obloženih tableta
English: Mysildecard contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 (PDE5) inhibitors.
Croatian: Mysildecard sadrži djelatnu tvar sildenafil, koji pripada skupini lijekova koji se nazivaju inhibitorima fosfodiesteraze tipa 5 (PDE5).
English: Co-administration with nitric oxide donors (such as amyl nitrite) or nitrates in any form due to the hypotensive effects of nitrates (see section 5.1).
Croatian: Istodobna primjena s donorima dušikova oksida (poput amil nitrita) ili nitratima u bilo kojem obliku, zbog hipotenzivnih učinaka nitrata (vidjeti dio 5.1).
English: A. MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE Name and address of the manufacturer(s) responsible for batch release Mylan Hungary Kft.
Croatian: PROIZVOĐAČ(I) ODGOVORAN(NI) ZA PUŠTANJE SERIJE LIJEKA U PROMET Naziv(i) i adresa(e) proizvođača odgovornog(ih) za puštanje serije lijeka u promet Mylan Hungary Kft.
English: Film coat: hypromellose (6mPas), titanium dioxide (E171) and triacetin.
Croatian: Film ovojnica: hipromeloza (6 mPas), titanijev dioksid (E171) i triacetin.
English: Riociguat: Preclinical studies showed additive systemic blood pressure lowering effect when PDE5 inhibitors were combined with riociguat.
Croatian: Riociguat: Pretklinička ispitivanja su pokazala dodatan učinak na sniženje sistemskog krvnog tlaka kada se PDE5 inhibitori koriste u kombinaciji sa riociguatom.
English: Other pharmaceutical forms are available for administration to patients ≤ 20 kg and other younger patients who are not able to swallow tablets.
Croatian: Drugi farmaceutski oblici su dostupni za primjenu u bolesnika tjelsne težine ≤ 20 kg i drugih mlađih bolesnika koji ne mogu progutati tablete.
English: The tablets are provided in blisters in packs containing 90, 300 and (90 x 1) tablets.
Croatian: Tablete se isporučuju u blister pakiranjima koja sadrže 90, 300 i (90 x 1) tableta
English: The 20 mg tablet should not be used in cases where 10 mg TID should be administered in younger patients.
Croatian: Tableta od 20 mg se ne bi trebala koristiti u slučajevima kada treba primijeniti 10 mg tri puta na dan u mlađih bolesnika.
English: Initial dose adjustments are not required in patients with renal impairment, including severe renal impairment (creatinine clearance < 30 ml/min).
Croatian: Nije potrebno prilagođavati početnu dozu u bolesnika s oštećenjem funkcije bubrega, uključujući i teško oštećenje bubrega (klirens kreatinina < 30 ml/min).
English: The tablets are marked with M on one side and SL over 20 on the other.
Croatian: M na jednoj strani tablete i SL over 20 na drugoj strani tablete.
English: • Therapies for pulmonary hypertension (e.g. bosentan, iloprost)
Croatian: lijekove za liječenje plućne hipertenzije (npr. bosentan, iloprost).
English: The efficacy and safety of sildenafil co-administered with other treatments for pulmonary arterial hypertension (e.g. ambrisentan, iloprost) has not been studied in controlled clinical trials.
Croatian: Djelotvornost i sigurnost sildenafila primijenjenog istodobno s drugim lijekovima za plućnu arterijsku hipertenziju (npr. ambrisentan, iloprost) nije ispitana u kontroliranim kliničkim ispitivanjima.
English: The European Medicines Agency has deferred the obligation to submit the results of studies with sildenafil in newborns with pulmonary arterial hypertension (see section 4.2 for information on paediatric use).
Croatian: Europska agencija za lijekove je odgodila obvezu podnošenja rezultata ispitivanja sildenafila u novorođenčadi s plućnom arterijskom hipertenzijom (vidjeti dio 4.2 za informacije o pedijatrijskoj primjeni).
English: PVC-Al blister packs containing 90 or 300 film-coated tablets.
Croatian: Blister od PVC Al koji sadrži 90 ili 300 filmom obloženih tableta.
English: Sildenafil is a weak inhibitor of the cytochrome P450 isoforms 1A2, 2C9, 2C19, 2D6, 2E1 and 3A4 (IC50 > 150 μM).
Croatian: Sildenafil je slab inhibitor izoformi 1A2, 2C9, 2C19, 2D6, 2E1 i 3A4 citokroma P450 (IC50 > 150 m).
English: The primary objective of the study was to assess the efficacy of 16 weeks of chronic treatment with oral sildenafil in paediatric subjects to improve exercise capacity as measured by the Cardiopulmonary Exercise Test (CPET) in subjects who were developmentally able to perform the test, n = 115).
Croatian: Primarni cilj istraživanja bio je procijeniti djelotvornost 16-tjednog kroničnog peroralnog liječenja sildenafilom u pedijatrijskih ispitanika na poboljšanje tjelesne sposobnosti, mjereno testom srčano-plućnog opterećenja (CPET test) u ispitanika koji su s obzirom na stupanj razvoja bili sposobni izvesti taj test (n = 115).
English: • Alpha-blocker therapy (e.g. doxazosin) for the treatment of high blood pressure or prostate problems, as the combination of the two medicines may cause symptoms resulting in the lowering of your blood pressure (e.g. dizziness, light headedness).
Croatian: alfa-blokatore (npr. doksazosin) za liječenje visokog krvnog tlaka ili tegoba s prostatom, jer kombinacija ovih dvaju lijekova može izazvati simptome niskog krvnog tlaka (npr. omaglicu, ošamućenost).
English: Patients with left ventricular ejection fraction < 45% or left ventricular shortening fraction < 0.2 were not studied.
Croatian: Bolesnici s istisnom frakcijom lijeve klijetke od < 45% ili frakcijom skraćenja lijeve klijetke od < 0,2 nisu ispitivani.
English: • have low blood pressure at rest.
Croatian: - imate nizak krvni tlak u mirovanju.
English: This medicinal product does not require any special storage condition.
Croatian: Za ovaj se lijek ne primjenjuju posebne mjere čuvanja.
English: Mysildecard should not be given to women of child bearing potential unless using appropriate contraceptive methods.
Croatian: Mysildecard se ne smije davati ženama reproduktivne dobi ako ne koriste odgovarajuće metode kontracepcije.
English: If you have an erection, which lasts continuously for more than 4 hours, stop taking Mysildecard and contact your doctor immediately (see also section 4).
Croatian: Ako imate erekciju, koja neprekidno traje dulje od 4 sata, prestanite uzimati Mysildecard i odmah se javite liječniku (pogledajte i dio 4).
English: In three specific drug-drug interaction studies, the alpha-blocker doxazosin (4 mg and 8 mg) and sildenafil (25 mg, 50 mg, or 100 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilised on doxazosin therapy.
Croatian: U tri specifična ispitivanja interakcija, lijekovi alfa-blokator doksazosin (4 mg i 8 mg) i sildenafil (25 mg, 50 mg ili 100 mg) su istovremeno primijenjeni bolesnicima s benignom hiperplazijom prostate (BHP), stabiliziranima na terapiji doksazosinom.
English: Patients were randomised to placebo or sildenafil (20 mg three times a day) in combination with bosentan (62.5-125 mg twice a day).
Croatian: Bolesnici su randomizirani u skupine sa placebom ili sa sildenafilom (20 mg tri puta na dan) u kombinaciji s bosentanom (62,5-125 mg dva puta na dan).
English: - The other ingredients are: Tablet core: microcrystalline cellulose (PH 102), calcium hydrogen phosphate anhydrous, croscarmellose sodium and magnesium stearate.
Croatian: - Drugi sastojci su: Jezgra tablete: mikrokristalična celuloza (PH 102), bezvodni kalcijev hidrogenfosfa, umreženi karmelozanatrij i magnezijev stearat.
English: 175 patients (63%) included were diagnosed with primary pulmonary hypertension, 84 (30%) were diagnosed with PAH associated with connective tissue disease and 18 (7%) of the patients were diagnosed with PAH following surgical repair of congenital heart lesions.
Croatian: 175 uključenih bolesnika (63%) imalo je dijagnozu primarne plućne hipertenzije, 84 (30%) dijagnozu PAH-a povezanog s bolešću vezivnog tkiva, a 18 (7%) dijagnozu PAH-a nastalog nakon kirurškog popravka prirođenih srčanih lezija.
English: In this trial, 63 of 234 (27%) patients were < 7 years old (sildenafil low dose = 2; medium dose = 17; high dose = 28; placebo = 16) and 171 of 234 (73%) patients were 7 years or older (sildenafil low dose = 40; medium dose = 38; and high dose = 49; placebo = 44).
Croatian: U tom ispitivanju, 63 od 234 (27%) bolesnika bila su mlađa od 7 godina (niska doza sildenafila = 2; srednja doza = 17; visoka doza = 28; placebo = 16), dok je 171 od 234 (73%) bolesnika imao 7 ili više godina (niska doza sildenafila = 40; srednja doza = 38, visoka doza = 49; placebo = 44).
English: Subjects who had been in the placebo group in the short-term study were randomly reassigned to sildenafil treatment; subjects weighing ≤ 20 kg entered the medium or high dose groups (1:1), while subjects weighing > 20 kg entered the low, medium or high dose groups (1:1:1).
Croatian: Ispitanici koji su bili u skupini koja je primala placebo u kratkotrajnom ispitivanju, bili su ponovno randomizirani za liječenje sildenafilom; ispitanici tjelesne težine ≤ 20 kg uključeni su u skupine sa srednjom ili visokom dozom (1:1), a ispitanici tjelesne težine > 20 kg uključeni su u skupine s niskom, srednjom ili visokom dozom (1:1:1).
English: Mysildecard is for oral use only.
Croatian: Mysildecard je namijenjen samo za peroralnu primjenu.
English: Subjects (38% male and 62% female) had a body weight ≥8 kg, and had primary pulmonary hypertension (PPH) [33%], or PAH secondary to congenital heart disease [systemic-to-pulmonary shunt 37%, surgical repair 30%].
Croatian: Ispitanici (38% muškog i 62% ženskog spola) su imali tjelesnu težinu  8 kg, a imali su primarnu plućnu hipertenziju (PPH) [33%] ili PAH kao posljedicu prirođene bolesti srca [sistemsko-plućni spoj u 37%, a kirurški zahvat u 30% slučajeva].
English: Suddenly stopping your treatment with Mysildecard may lead to your symptoms getting worse.
Croatian: Nagli prekid liječenja lijekom Mysildecard može dovesti do pogoršanja simptoma.
English: • if you have ever had loss of vision because of a problem with blood flow to the nerve in the eye called non-arteritic anterior ischaemic optic neuropathy (NAION).
Croatian: - ako ste ikada doživjeli gubitak vida zbog problema s dotokom krvi u očni živac - stanja koje se zove nearterijska prednja ishemijska neuropatija vidnog živca.
English: • Medicines containing St. John's Wort (herbal medicinal product), rifampicin (used to treat bacterial infections), carbamazepine, phenytoin and phenobarbital (used, among others, to treat epilepsy)
Croatian: lijekove koji sadrže gospinu travu (biljni lijek), rifampicin (koristi se za liječenje bakterijskih infekcija), karbamazepin, fenitoin i fenobarbital (koriste se, između ostalog, za liječenje epilepsije).